The TREAT PTSD Act mandates the provision of stellate ganglion block therapy to veterans and Armed Forces members diagnosed with post-traumatic.
The TREAT PTSD Act, or Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, requires the Secretary of Veterans Affairs and the Secretary of Defense to provide stellate ganglion block therapy to veterans and members of the Armed Forces diagnosed with post-traumatic stress disorder. This therapy is available to those enrolled in the patient enrollment system or the TRICARE program, respectively, and who have chosen to receive it after being informed of its risks and benefits.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.